New York City-based Memorial Sloan Kettering Cancer Center is partnering with AstraZeneca and Sophia Genetics to bring its proprietary liquid biopsy and solid tumor cancer tests to a global market, according to an Oct. 18 news release. 

Here are nine systems and organizations developing artificial intelligence models to find and treat cancer faster:

Julie Gralow, MD, was named Woman Oncologist of the Year by Women Leaders in Oncology.

U.S. News & World Report evaluated 899 hospitals across the country and ranked them for treating leukemia, lymphoma, melanoma, breast, kidney, colon, prostate, pancreatic, head and neck, orthopedic, uterine and ovarian cancers.

Even though a majority of breast cancer cases are diagnosed without a lump that can be detected, less than half recognize other symptoms often associated with it, according to new research from the Ohio State University Comprehensive Cancer Center.

Mass General Brigham President and CEO Anne Klibanski, MD, shared a muted reaction to longtime affiliate Dana-Farber Cancer Institute's decision to partner with another Boston health system for cancer care in a recent op-ed with the Boston Globe. 

Results from a pilot study led by New York City-based Memorial Sloan Kettering Cancer Center suggest that a single blood test may be able to detect the presence of 50 different cancer types, according to an Oct. 13 news release. 

More than 1.9 million people are estimated to develop new cancer cases and more than 609,000 are estimated to die of cancer in 2023, according to estimates compiled by the American Cancer Society.

HCA Healthcare's Johnston-Willis Hospital in Richmond, Va., is the first in the nation to provide a new treatment for patients with brain metastases from lung cancer.

An emerging artificial intelligence-powered tool, known as Sturgeon, successfully diagnosed 45 out of 50 frozen brain tumor samples in a matter of just 40 minutes. In living patients, the tool was capable of accurately diagnosing 18 out of 25 cases, according to a study published Oct. 11 in Nature.

Detroit-based Karmanos Cancer Institute launched a questionnaire that identifies high-risk cancer patients with a few extra questions.

The recurrence of prostate cancer can now be detected 14.8 months sooner than existing clinical practices with new technology developed by a professor at Purdue University in West Lafayette, Ind.

After nine years, Baltimore-based Johns Hopkins and Pittsburgh-based Allegheny Health Network have announced that they will end their cancer center collaboration, TribLive reported Oct. 6.

Duarte, Calif.-based City of Hope will open the first multicenter clinical trial in the U.S. to test robotically assisted mastectomies, according to an Oct. 3 news release shared with Becker's.

Hung-Chi Ho, MD, a board-certified radiation oncologist at University of Pittsburgh Medical Center's Hillman Cancer Center in Butler, Pa., will retire after a 37-year career with the health system.

Rochester, Minn.-based Mayo Clinic is utilizing artificial intelligence to achieve earlier detection of pancreatic cancer in patients while the disease is still curable, according to an Oct. 2 news release.

Patients who have multiple myeloma and also diabetes are at an increased risk of lower survival rates, but new research shows this differs by race.

Healthcare professionals said health disparities and inadequate treatment options are their top concerns in oncology, according to a recent poll from Becker's on LinkedIn.

Six types of cancer were underdiagnosed during the pandemic, according to the National Institutes of Health.

Boston-based Mass General Cancer Center has received the largest philanthropic gift in its history to be put toward future cancer research, according to a Sept. 27 news release.